RainBIO is at the forefront of ocular gene therapy, specifically targeting corneal blindness through innovative approaches. The company utilizes adeno-associated virus (AAV) vector gene therapy, which is designed to directly correct cellular functions in the cornea. This technology aims to maintain or restore vision in patients suffering from various diseases that threaten their sight. Notably, RainBIO's lead program addresses corneal clouding associated with Mucopolysaccharidosis type 1 (MPS1), a rare genetic disorder that can lead to significant vision loss. This pioneering effort represents a significant advancement in the field of ocular gene therapy, opening new avenues for treatment.

Founded by a team of scientists from the University of North Carolina and NC State University, RainBIO is driven by a mission to provide transformative solutions for patients facing blindness. The company is supported by a management team with extensive experience in the field, including leaders from the Foundation Fighting Blindness and academia. Their collaborative efforts underscore a commitment to developing therapies that can significantly improve the quality of life for individuals affected by corneal diseases, marking a promising step forward in the realm of genetic treatments for ocular conditions.

United States

Rainbow Company Youth Theatre is a nationally acclaimed, award-winning youth theatre group funded by the city of Las Vegas. For more than 45 years, the Rainbow Company has been providing quality theatre experiences for young people and their families.

RainBIO

Company Details